Exit Options for John Hancock Bond and Corporate Finance Group: Hanover Communications In... - 28 Strategic Investors

View x

Israel's V-Wave secures $28 million in Series B funds

  • Region:


  • Sector:

    Consumer Services

  • Deal Size:

    $28 million

  • Buy Side Company:

    BRM Group, Pontifax, Johnson & Johnson Innovation, TriVentures, BioStar Ventures
  • Sell Side Company:

    V-Wave Ltd
  • Target Company:

Israel-based V-Wave Ltd, which is developing an implantable, inter-atrial shunt that treats heart failure, has secured $28 million in Series B funding. New investors in this round included Johnson & Johnson Innovation - JJDC Inc, TriVentures, Pura Vida Investments and BioStar Ventures. Existing backers BRM Group, Pontifax and Edwards Lifesciences also participated in the round. The funds will support clinical evaluation and development, addition of senior management and manufacturing scale-up of V-Wave’s proprietary device.


VC Deals,BioStar Ventures,BRM Group,Edwards Lifesciences,heart failure,Johnson & Johnson Innovation-JJDC Inc,Pontifax,Pura Vida Investments,TriVentures,V-Wave